Showing results (91-100 of 111) with videos related to

Sort By:
Pageof 12
Frontiers in Neurology|April 19, 2024
Combination therapy of Epidermal Growth Factor and Growth Hormone-Releasing Hexapeptide in acute ischemic stroke: a phase I/II non-blinded, randomized clinical trialFrancisco Hernández-Bernal, Donner Estenoz-García, Juan H Gutiérrez-Ronquillo, et al.
Lancet Regional Health. Americas|May 3, 2024
Real-world effectiveness of the heterologous SOBERANA-02 and SOBERANA-Plus vaccine scheme in 2-11 years-old children during the SARS-CoV-2 Omicron wave in Cuba: a longitudinal case-population studyMaría Eugenia Toledo-Romaní, Carmen Valenzuela-Silva, Minerva Montero-Díaz, et al.
Vaccines|December 24, 2025
Safety and Cross-Neutralizing Immunity Against SARS-CoV-2 Omicron Sub-Variant After a Booster Dose with SOBERANA® Plus in Children and AdolescentsDagmar García-Rivera, Meiby Rodríguez-González, Beatriz Paredes-Moreno, et al.
Clinical & Translational Immunology|December 11, 2020
Treatment of COVID-19 patients with the anti-CD6 antibody itolizumabArmando Caballero, Lázaro M Filgueira, Julio Betancourt, et al.
ACS Pharmacology & Translational Science|February 22, 2021
Treatment with an Anti-CK2 Synthetic Peptide Improves Clinical Response in COVID-19 Patients with Pneumonia. A Randomized and Controlled Clinical TrialLeticia R Cruz, Idania Baladrón, Aliusha Rittoles, et al.
Vaccine: X|December 31, 2024
Safety and durability of the immune response after vaccination with the heterologous schedule of anti-COVID-19 vaccines SOBERANA®02 and SOBERANA® Plus in children 3-18 years oldDagmar García-Rivera, Rinaldo Puga-Gómez, Sonsire Fernández-Castillo, et al.
Medrxiv : the Preprint Server for Health Sciences|December 23, 2024
Kir2.1 mutations differentially increase the risk of flecainide proarrhythmia in Andersen Tawil SyndromeFrancisco M Cruz, Ana I Moreno-Manuel, Patricia Sánchez Pérez, et al.
International Immunopharmacology|May 17, 2024
Long-term therapy with itolizumab is safe and effective for patients with moderate to severe psoriasis: Results from an expanded-access programLeopoldina Falcón Lincheta, Yaimarelis Saumell Nápoles, Olaine R Gray Lovio, et al.
Biologicals : Journal of the International Association of Biological Standardization|October 24, 2006
Immunogenicity and safety assessment of the Cuban recombinant hepatitis B vaccine in healthy adultsZurina Cinza Estévez, Arístides Aguilar Betancourt, Verena Muzio González, et al.
JAMA Network Open|May 3, 2023
Efficacy and Safety of a Protein-Based SARS-CoV-2 Vaccine: A Randomized Clinical TrialEhsan Mostafavi, Sana Eybpoosh, Mohammad Karamouzian, et al.
Pageof 12